Angélo Paci

6.2k total citations
201 papers, 3.5k citations indexed

About

Angélo Paci is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Angélo Paci has authored 201 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 43 papers in Oncology and 38 papers in Surgery. Recurrent topics in Angélo Paci's work include Cancer, Hypoxia, and Metabolism (16 papers), Cancer therapeutics and mechanisms (13 papers) and Chemotherapy-induced organ toxicity mitigation (13 papers). Angélo Paci is often cited by papers focused on Cancer, Hypoxia, and Metabolism (16 papers), Cancer therapeutics and mechanisms (13 papers) and Chemotherapy-induced organ toxicity mitigation (13 papers). Angélo Paci collaborates with scholars based in France, Italy and United Kingdom. Angélo Paci's co-authors include Gareth J. Veal, Étienne Chatelut, A. Astier, Christophe Bardin, Dominique Levêque, Jos H. Beijnen, Nicolas Widmer, Gilles Vassal, Alain Deroussent and Sophie Broutin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Angélo Paci

195 papers receiving 3.5k citations

Peers

Countries citing papers authored by Angélo Paci

Since Specialization

Citations

This map shows the geographic impact of Angélo Paci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angélo Paci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angélo Paci more than expected).

Fields of papers citing papers by Angélo Paci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angélo Paci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angélo Paci. The network helps show where Angélo Paci may publish in the future.

Co-authorship network of co-authors of Angélo Paci

This figure shows the co-authorship network connecting the top 25 collaborators of Angélo Paci. A scholar is included among the top collaborators of Angélo Paci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angélo Paci. Angélo Paci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacogenetics in oncology: Unveiling its potential in treatment personalization and beyond 2025 ·Bulletin du Cancer ·(unknown), Angélo Paci, Tiphaine Adam de Beaumais, Etienne Rouleau	0
2	Nivolumab plasma concentration and clearance associated with overall survival in patients with renal cell carcinoma 2025 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), Cécile Dalban, (unknown), Sophie Broutin, Aurélien Marabelle, Laurence Albigès, Angélo Paci	2
3	“Cyclophosphamide and analogues; a matter of dose and schedule for dual anticancer activities” 2024 ·Cancer Letters ·(unknown), (unknown), Angélo Paci	7
4	Elevated mortality risks associated with late diagnosis of cancer in individuals with psychiatric disorders? 2024 ·Journal of Psychiatric Research ·(unknown), (unknown), Angélo Paci, Luca Pellegrini, Gabriele Di Salvo, (unknown), (unknown), Stefano Negro, Umberto Albert	1
5	Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy 2024 ·SHILAP Revista de lepidopterología ·(unknown), Arnaud Wiedemann, Gérard Michel, Jean‐Hugues Dalle, Fanny Rialland, C. Rénard, Charlotte Jubert, Johan Maertens, Anne Sîrvent, (unknown), Christine Devalck, Bénédicte Brichard, Catherine Paillard, Stéphanie Nguyen, Angélo Paci, (unknown), Martin Castelle, Simona Pagliuca, Cécile Pochon	0
6	1166MO Clinical evaluation of serum succinate levels as a new biomarker in SDH-related paragangliomas and pheochromocytomas 2020 ·Annals of Oncology ·(unknown), (unknown), Matthieu Faron, Éric Baudin, Sophie Leboulleux, Angélo Paci, Julien Hadoux, Sophie Broutin	2
7	1,1-Diheterocyclic Ethylenes Derived from Quinaldine and Carbazole as New Tubulin-Polymerization Inhibitors: Synthesis, Metabolism, and Biological Evaluation 2018 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Olivier Provot, Jérôme Bignon, Hélène Levaïque, Joëlle Dubois, Martin Soucé, Athéna Kasselouri, Alain Deroussent, Angélo Paci, Paloma F. Varela, Benoı̂t Gigant, Mouâd Alami, Abdallah Hamzé	51
8	Therapeutic Drug Monitoring of Carboplatin in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors: Pharmacokinetic Results of a Phase II Multicenter Study 2017 ·Clinical Cancer Research ·(unknown), Christine Chevreau, Sophie Broutin, Jérôme Guitton, Bénédicte Lelièvre, Joseph Ciccolini, (unknown), Aude Fléchon, R. Delva, Gwénaëlle Gravis, Jean‐Pierre Lotz, Jacques‐Olivier Bay, Marine Gross‐Goupil, Angélo Paci, (unknown), (unknown), Étienne Chatelut, Fabienne Thomas	14
9	Efficacy of 5-Azacitidine on IDH1/2 Acute Myeloid Leukemia/Myelodysplastic Syndromes and Correlation with 2-Hydroxyglutarate Production 2017 ·Blood ·Christophe Willekens, Véronique Saada, Sophie Broutin, (unknown), Aline Renneville, (unknown), Christophe Marzac, Jean‐Baptiste Micol, Éric Solary, Florence Pasquier, Julien Lazarovici, Vincent Ribrag, Claude Preudhomme, Cyril Quivoron, Virginie Penard‐Lacronique, Angélo Paci, Stéphane de Botton	1
10	Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee 2016 ·Biology of Blood and Marrow Transplantation ·Jeanne Palmer, Jeannine S. McCune, Miguel‐Angel Perales, David I. Marks, Joseph Bubalo, Mohamad Mohty, John R. Wingard, Angélo Paci, Moustapha Hassan, Christopher Bredeson, Joseph Pidala, Nina Shah, Paul Shaughnessy, Navneet S. Majhail, Jeff Schriber, Bipin N. Savani, Paul A. Carpenter	110
11	Lipoprotein-Free Mitotane Exerts High Cytotoxic Activity in Adrenocortical Carcinoma 2015 ·The Journal of Clinical Endocrinology & Metabolism ·S. Hescot, Atmane Seck, Maryse Guérin, (unknown), Thierry Huby, Sophie Broutin, Jacques Young, Angélo Paci, Eric Baudin, Marc Lombès	27
12	Variation in transplacental transfer of tyrosine kinase inhibitors in the human perfused cotyledon model 2015 ·Annals of Oncology ·Cécile Jovelet, Atmane Seck, Olivier Mir, (unknown), Sophie Broutin, François Goffinet, Jean‐Michel Bidart, Angélo Paci, Sophie Gil	21
13	Review of therapeutic drug monitoring of anticancer drugs part two – Targeted therapies 2014 ·European Journal of Cancer ·Nicolas Widmer, Christophe Bardin, Étienne Chatelut, Angélo Paci, Jos H. Beijnen, Dominique Levêque, Gareth J. Veal, A. Astier	240
14	Vemurafenib in pediatric patients with BRAFV600E mutated high‐grade gliomas 2013 ·Pediatric Blood & Cancer ·Francisco Bautista, Angélo Paci, Véronique Minard‐Colin, Christelle Dufour, Jacques Grill, Ludovic Lacroix, Pascale Varlet, Dominique Valteau‐Couanet, Birgit Geoerger	105
15	Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells 2013 ·Endocrine Related Cancer ·S. Hescot, Abdelhamid Slama, Anne Lombès, Angélo Paci, (unknown), Sophie Leboulleux, Rita Chadarévian, Séverine Trabado, Larbi Amazit, Jacques Young, Éric Baudin, Marc Lombès	76
16	Pharmacokinetic Behavior and Appraisal of Intravenous Busulfan Dosing in Infants and Older Children 2012 ·Therapeutic Drug Monitoring ·Angélo Paci, Gilles Vassal, Despina Moshous, Jean‐Hugues Dalle, Nathalie Bleyzac, Bénédicte Neven, Claire Galambrun, Véronique Kemmel, Zeinab Abdi, Sophie Broutin, Aurélie Pétain, Laurent Nguyen	65
17	Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours 2010 ·European Journal of Cancer ·Hervé Rubie, Birgit Geoerger, Didier Frappaz, Antonin Schmitt, Pierre Leblond, Anna Julienne Selbé Ndiaye, Isabelle Aerts, Marie‐Cécile Le Deley, Jean‐Claude Gentet, Angélo Paci, Pascal Chastagner, Nathalie Dias, (unknown), Marlène Pasquet, Étienne Chatelut, Judith Landman‐Parker, Nadège Corradini, Gilles Vassal	15
18	Microbiological and Physicochemical Stability of Oxycodone Hydrochloride Solutions for Patient-Controlled Delivery Systems 2010 ·Journal of Pain and Symptom Management ·A. Amri, (unknown), Élisabeth Chachaty, (unknown), Philippe Bourget, Angélo Paci	5
19	Squalenoylation a new concept in drug targeting: evidence of a potent anti-cancer activity of squalenoyl-gemcitabine 2008 ·Cancer Research ·(unknown), L. Harivardhan Reddy, Lucien Bildstein, Alain Deroussent, Catherine Dubernet, Patrick Couvreur, Gilles Vassal, Angélo Paci	1
20	Acoustic characterization of a new trisacryl contrast agent. Part I: In vitro study 2007 ·Ultrasonics ·(unknown), Valérie Rouffiac, P. Péronneau, Angélo Paci, (unknown), (unknown), Alain Roche, Nathalie Lassau	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact